Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Accumulated Expenses: 2016-2024

Historic Accumulated Expenses for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $39.5 million.

  • Organogenesis Holdings' Accumulated Expenses rose 11.66% to $40.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.3 million, marking a year-over-year increase of 11.66%. This contributed to the annual value of $39.5 million for FY2024, which is 31.19% up from last year.
  • Per Organogenesis Holdings' latest filing, its Accumulated Expenses stood at $39.5 million for FY2024, which was up 31.19% from $30.1 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Accumulated Expenses ranged from a high of $39.5 million in FY2024 and a low of $24.0 million during FY2020.
  • In the last 3 years, Organogenesis Holdings' Accumulated Expenses had a median value of $30.1 million in 2023 and averaged $32.0 million.
  • As far as peak fluctuations go, Organogenesis Holdings' Accumulated Expenses spiked by 55.55% in 2021, and later dropped by 29.08% in 2022.
  • Yearly analysis of 5 years shows Organogenesis Holdings' Accumulated Expenses stood at $24.0 million in 2020, then spiked by 55.55% to $37.3 million in 2021, then decreased by 29.08% to $26.4 million in 2022, then rose by 13.71% to $30.1 million in 2023, then skyrocketed by 31.19% to $39.5 million in 2024.